
Opinion|Videos|September 20, 2024
AI and the Future of Biomarkers in Prostate Cancer
Prostate cancer specialists share their insights on anticipated future advancements that could significantly influence prostate cancer management strategies.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- What future advancements in testing protocols do you anticipate, and how might they impact the management of prostate cancer?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
2
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
3
Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer
4
Amy E. Krambeck, MD, on choosing between CVAC and FANS for suction-based ureteroscopy
5


















